Gabriel N. Hortobagyi

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases

Allan Lipton, Richard L. Theriault, Gabriel N. Hortobagyi et al. · Cancer · 2000 · 673 citations

Medicine, Oncology, Pharmacotherapy +17

Clinical course of breast cancer patients with liver metastases.

Juan W Zinser, Gabriel N. Hortobagyi, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1987 · 169 citations

Medicine, Oncology, Breast Oncology +16

Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma

Gabriel N. Hortobagyi, Aman U. Buzdar, Richard L. Theriault et al. · JNCI Journal of the National Cancer Institute · 2000 · 169 citations

Medicine, Oncology, Breast Oncology +14

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.

Zillur Rahman, D. Frye, Aman U. Buzdar et al. · Journal of Clinical Oncology · 1997 · 155 citations

Medicine, Oncology, Pharmacology +15

Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.

Lianglin Zhang, Y.K. James Lau, Weiya Xia et al. · PubMed · 1999 · 151 citations

Medicine, Oncology, Pharmacology +17